Home About us Current issue Ahead of Print Back issues Submission Instructions Advertise Contact Login   

Search Article 
Advanced search 
Saudi Journal of Kidney Diseases and Transplantation
Users online: 1407 Home Bookmark this page Print this page Email this page Small font sizeDefault font size Increase font size 

    Article Cited by others


Response to rituximab in a refractory case of thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus

Niaz Faraz Azim, Aleem Aamer

Year : 2010| Volume: 21| Issue : 1 | Page no: 109-112

   This article has been cited by
1 Anti B-cell therapy against refractory thrombocytopenia in SLE and MCTD patients: Long-term follow-up and review of the literature
Jovancevic, B. and Lindholm, C. and Pullerits, R.
Lupus. 2013; 22(7): 664-674
[Pubmed]  [Google Scholar]
2 Efficacy of rituximab in acute refractory or chronic relapsing non-familial idiopathic thrombotic thrombocytopenic purpura: A systematic review with pooled data analysis
Tun, N.M. and Villani, G.M.
Journal of Thrombosis and Thrombolysis. 2012; 34(3): 347-359
[Pubmed]  [Google Scholar]
3 Application of biological agents for treatment of patients with systemic lupus erythematosus [Zastosowanie leków biologicznych w terapii tocznia rumieniowatego układowego]
Kramza, J. and Kucharz, E.J.
Reumatologia. 2011; 49(4): 264-274
[Pubmed]  [Google Scholar]
4 Targeting B cells to treat systemic lupus erythematosus
Tieng, A.T. and Zandman-Goddard, G. and Peeva, E.
International Journal of Clinical Rheumatology. 2010; 5(6): 627-636
[Pubmed]  [Google Scholar]


Read this article